Karl-Anthony Towns Partnered With Sanofi for Vaccine
The NBA champion and New York Knicks star is promoting the newly approved 2026-27 NUVAXOVID vaccine formula.
Updated on Oct. 5, 2026 in Basketball
Live Poll
Should professional athletes actively partner with pharmaceutical companies to promote medical vaccines?
NBA star Karl-Anthony Towns has partnered with Sanofi to raise awareness for the 2026-27 NUVAXOVID vaccine. The initiative follows the FDA's August 2026 approval of the new formula, which is designed to target the XFG variant.
Why it matters
Towns, who has asthma, cites his family's tragic history with the virus as his primary motivation for health advocacy. His decision to promote the protein-based vaccine highlights the influence of personal experience on high-profile public health messaging.
The FDA approved the 2026-27 NUVAXOVID formula in August 2026 to target the circulating XFG variant. Towns' advocacy follows a career year in which he helped the New York Knicks secure a championship.
The players
Karl-Anthony Towns
He is a professional basketball player for the New York Knicks who recently helped the team win an NBA championship.
Sanofi
This global healthcare company develops and manufactures various pharmaceutical products and vaccines.
Jordyn Woods
She is a model and entrepreneur who married Karl-Anthony Towns in August 2026.
The details
Towns, whose mother was a nurse, emphasized his preference for non-mRNA options when choosing his own vaccine. He has been deeply affected by the pandemic, having lost his mother and seven other relatives to complications from the virus.
Timeline
Jacqueline Cruz-Towns passed away from COVID-19 in April 2020.
Towns lost eight relatives to the virus throughout 2020.
The FDA approved the new NUVAXOVID formula in August 2026.
Karl-Anthony Towns and Jordyn Woods were married on August 15, 2026.
The Big Picture
This promotional effort follows the regulatory framework set by the FDA's 2026-27 vaccine approval protocols. The initiative underscores how star athletes leverage their platforms to promote specific health measures following major updates in pharmaceutical guidance.
The public endorsement by an NBA champion provides visibility for the protein-based vaccine option available to the general public. Readers can discuss vaccination options that include non-mRNA alternatives with their primary care physicians.
The takeaway
Maintaining up-to-date vaccinations remains a recommended strategy for individuals with high-risk health conditions like asthma. Public health awareness campaigns led by trusted community voices continue to be a primary method for disseminating medical guidance.
Further reading
For more on professional players and their off-court initiatives, visit the Basketball section.
Live Poll
Should professional athletes actively partner with pharmaceutical companies to promote medical vaccines?
